Aging clues in cells may unlock fertility secrets for women after failed IVF
NCT ID NCT07404969
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether measuring telomeres—parts of our cells linked to aging—can help explain why some women still can't get pregnant even after fertility treatments. Fifteen women aged 25 to 42 will get blood tests to check their biological age, then receive a personalized plan combining traditional Chinese medicine, nutrition, and standard fertility care. The goal is to see if this approach improves pregnancy rates and reveals new insights into unexplained infertility.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Telomere and aging biomarker profiling, Traditional Chinese Medicine, nutritional support
- What this could lead to
- If successful, this could lead to a personalized approach to improve pregnancy chances in women with unexplained infertility after failed fertility treatments.
- What could go wrong
- This is a very small early study with only 15 participants, so results may not apply to everyone. The integrative approach may not improve pregnancy rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 42 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Biological female participants aged 25 to 42 years. * Diagnosis of infertility defined as failure to conceive after at least 12 months of unprotected intercourse and/or repeated failure of assisted reproductive technologies (ART), including intrauterine insemination (IUI) and/or in vitro fertilization (IVF). * History of post-treatment unexplained or functionally idiopathic infertility, defined as persistent infertility despite adequate correction or management of identifiable reproductive conditions (e.g., endometriosis, polycystic ovary syndrome, hormonal imbalance, uterine factors). * Eligibility for natural conception attempts and/or assisted reproductive technologies according to routine clinical practice. * Willingness to undergo biological aging biomarker profiling, including leukocyte telomere analysis. * Ability and willingness to comply with study procedures, including the preconception integrative intervention and follow-up assessments. * Provision of written informed consent prior to participation. Exclusion Criteria: * Current pregnancy or breastfeeding at the time of enrollment. * Known chromosomal abnormalities or genetic conditions directly impairing fertility (e.g., Turner syndrome). * Untreated severe male factor infertility precluding conception by natural or standard ART methods. * Active malignancy or history of cancer requiring systemic treatment within the past 5 years. * Severe systemic disease or medical condition contraindicating pregnancy or participation in ART (as determined by the treating physician). * Use of investigational drugs or participation in another interventional clinical trial that could interfere with the study outcomes. * Known hypersensitivity or contraindication to components of the integrative intervention, as determined by clinical assessment. * Any condition which, in the opinion of the investigator, would interfere with safe participation or interpretation of study results.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Idiopathic infertility are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
BEYOND GENOMiX Research and Coordination Center
RECRUITINGNeuchâtel, 2000, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antioxidant supplement tested as fertility booster for PCOS
- Do infertility treatments leave a metabolic mark on children?
- Sperm sorting showdown: can a microchip pick the best sperm for pregnancy?
- Can AI learn to spot endometriosis and fibroids on ultrasound?
- One shot instead of many: a simpler path to IVF egg retrieval?
- Can sex boost the odds of IVF success?